Sign in

CIK 0001880438 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

AN2 Therapeutics, Inc.

Sign in to watch
Ticker
ANTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
820606654
Phone
(650) 331-9090
Business address
1300 EL CAMINO REAL, SUITE 100, MENLO PARK, CA, 94025
  1. 424B3 Offering Prospectus
  2. 424B5 Offering Prospectus
  3. CORRESP Other Correspondence Between Filers and SEC Staff
  4. UPLOAD Other SEC-generated Letter
  5. S-3 Offering Registration Statement
  6. 424B5 Offering Prospectus
  7. 424B5 Offering Prospectus
  8. CORRESP Other Correspondence Between Filers and SEC Staff
  9. UPLOAD Other SEC-generated Letter
  10. S-3 Offering Registration Statement
  11. 424B4 Offering Prospectus
  12. CORRESP Other Correspondence Between Filers and SEC Staff
  13. CORRESP Other Correspondence Between Filers and SEC Staff
  14. S-1/A Offering Registration Statement
  15. S-1 Offering Registration Statement
  16. UPLOAD Other SEC-generated Letter
  17. UPLOAD Other SEC-generated Letter

Page 1 of 1 · 17 filings